We advise healthcare and life sciences companies, healthcare providers, sponsors and financial institutions on regulatory, operational and transactional matters relating to the healthcare and pharmaceutical sectors in Indonesia. Our work spans pharmaceuticals, medical devices, healthcare services, hospitals and clinics, as well as healthcare-related distribution and manufacturing activities.

We regularly advise multinational pharmaceutical and life sciences companies on ongoing operational and regulatory compliance, including licensing and permits, data protection, employment and immigration matters, internal investigations, and workforce restructuring. Our experience includes advising on complex restructurings, spin-offs and divestments, as well as regulatory-sensitive operational changes affecting manufacturing, distribution and commercial activities.

 We also advise on investments, acquisitions and financings involving healthcare platforms, hospitals, clinics and pharmaceutical businesses, including cross-border transactions and private equity investments. In addition, we advise on regulatory and compliance issues relating to digital healthcare initiatives and healthcare-related technology deployments, as well as healthcare aspects of capital markets and financing transactions.